Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Vincent Frontera


Postdoctoral Researcher

After completing my PhD degree in Immunology, I joined the team of Professor Alexander Medvinsky, in Edinburgh. There, I developed a special interest in the process of Endothelial-to-Hematopoietic Transition (EHT) involved in blood emergence within mouse embryos. So, I decided to start a postdoctoral fellowship in the lab of Professor Marella de Bruijn, who describe the importance of a master transcription factor of EHT, Runx1.

 In her lab, I have been involved in several projects on embryonic hematopoiesis. I have been particularly fascinated by the characterization of Runx1 cis-elements, that will elucidate the trans-acting factors which trigger EHT. I established, in collaboration with other members of the lab, the Runx1 enhancer-specific activity within discreet cell populations by using novel transgenic enhancer-reporter mouse lines. This work represent an incredible opportunity to have a better understanding of Runx1 regulation and may suggest new approaches for in vitro generation of hematopoietic stem cells.

During my previous experiences, I have developed a strong expertise in FACS, in vivo experiments, and cell biology techniques. Being a postdoc with Professor Marella de Bruijn at the WIMM, I have been well initiated to mouse ES cell system and molecular biology techniques as RNA-seq, ATAC-seq, Chip-qPCR and CRISPR/Cas9 technology.